Revised guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ayliffe, 1973, Dispersal and skin carriage of staphylococci in healthy male and female subjects and patients with skin disease, 435
Ayliffe, 1984
Baird, 1987, Mupirocin-resistant Staphylococcus aureus, Lancet, 2, 387
Bartzokas, 1984, Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit, New England Journal of Medicine, 311, 1422, 10.1056/NEJM198411293112207
Blowers, 1973, Shedding of Staph. aureus by human carriers, 432
Brumfitt, 1985, Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus, Lancet, 1, 1442, 10.1016/S0140-6736(85)91863-X
Cafferkey, 1982, Severe staphylococcal infections treated with vancomycin, Journal of Antimicrobial Chemotherapy, 9, 69, 10.1093/jac/9.1.69
Carmichael, 1986, Pancytopenia associated with vancomycin, British Medical Journal, 293, 1103, 10.1136/bmj.293.6554.1103-c
Casewell, 1984, The effect of mupirocin on the nasal carriage of Staphylococcal aureus, 149
Casewell, 1985, In-vitro activity of mupirocin (‘pseudomonic acid’) against Clinical isolates of Staphylococcus aureus, Journal of Antimicrobial Chemotherapy, 15, 523, 10.1093/jac/15.5.523
Casewell, 1987, Mupirocin—a promising new antimicrobial for topical use, Journal of Antimicrobial Chemotherapy, 19, 1, 10.1093/jac/19.1.1
Chambers, 1984, Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, 26, 61, 10.1128/AAC.26.1.61
Cheng, 1988, Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong, Journal of Hospital Infection, 12, 91, 10.1016/0195-6701(88)90131-4
Cole, 1985, Allergy, red man syndrome, and vancomycin, Lancet, 2, 280, 10.1016/S0140-6736(85)90333-2
Cookson, 1988, Epidemic methicillin-resistant Staphylococcus aureus, Journal of Antimicrobial Chemotherapy, 21, 57, 10.1093/jac/21.suppl_C.57
Cookson, 1987, Control of epidemic methicillin-resistant Staphylococcus aureus, Lancet, 1, 696, 10.1016/S0140-6736(87)90471-5
Cookson, 1986, A hospital computer system as a tool for infection control, 126
Cookson, 1989, Staff carriage of epidemic methicillin-resistant Staphylococcus aureus, Journal of Clinical Microbiology, 27, 1471, 10.1128/JCM.27.7.1471-1476.1989
Davis, 1986, The ‘red man's syndrome’ and slow infusion of vancomycin, Annals of Internal Medicine, 104, 285, 10.7326/0003-4819-104-2-285_2
Dowsett, 1980, Eradicating staphylococci, Journal of Antimicrobial Chemotherapy, 6, 151, 10.1093/jac/6.1.151-a
Duckworth, 1986, New method for typing Staphylococcus aureus resistant to methicillin, British Medical Journal, 293, 885, 10.1136/bmj.293.6551.885-b
Duckworth, 1988, Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospital, Journal of Hospital Infection, 11, 1, 10.1016/0195-6701(88)90034-5
Duckworth, 1986, A comparison of the bactericidal activity of various agents against epidemic methicillin-resistant Staphylococcus aureus (EMRSA), 22, xiv
Faville, 1978, Staphylococcus aureus endocarditis: combined therapy with vancomycin and rifampicin, Journal of the American Medical Association, 240, 1963, 10.1001/jama.240.18.1963
Foldes, 1983, In-vitro effects of vancomycin, rifampicin and fusidic acid, alone and in combination against methicillin-resistant Staphylococcus aureus, Journal of Antimicrobial Chemotherapy, 11, 21, 10.1093/jac/11.1.21
Foster, 1986, Comparison of in-vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies, Antimicrobial Agents and Chemotherapy, 30, 823, 10.1128/AAC.30.6.823
Gaston, 1988, Evaluation of electrophoretic methods for typing methicillin-resistant Staphylococcus aureus, Journal of Medical Microbiology, 26, 189, 10.1099/00222615-26-3-189
Grant, 1986, Teicoplanin-resistant coagulase-negative staphylococcus, Lancet, 2, 1166, 10.1016/S0140-6736(86)90580-5
Grüneberg, 1980, Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin, Journal of Antimicrobial Chemotherapy, 6, 562, 10.1093/jac/6.4.562
Haley, 1985, Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus, Journal of Clinical Microbiology, 21, 991, 10.1128/JCM.21.6.991-992.1985
Hill, 1988, Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak, Journal of Antimicrobial Chemotherapy, 22, 377, 10.1093/jac/22.3.377
Mandell, 1972, Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies, Journal of Infectious Diseases, 125, 486, 10.1093/infdis/125.5.486
Marples, 1988, Current problems with methicillin-resistant Staphylococcus aureus, Journal of Hospital Infection, 11, 381, 10.1016/0195-6701(88)90093-X
Marples, 1986, Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance, Journal of Hygiene (Cambridge), 96, 217, 10.1017/S0022172400065980
Martin-Bouyer, 1982, Outbreak of accidental hexachlorophene poisoning in France, Lancet, 1, 91, 10.1016/S0140-6736(82)90225-2
McDougal, 1986, The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins, Journal of Clinical Microbiology, 23, 832, 10.1128/JCM.23.5.832-839.1986
Pauluzzi, 1987, Treatment of infections by staphylococci and other Gram-positive bacteria with teicoplanin: an open study, Journal of Antimicrobial Chemotherapy, 20, 431, 10.1093/jac/20.3.431
Pavillard, 1982, Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals, Medical Journal of Australia, 1, 451, 10.5694/j.1326-5377.1982.tb132413.x
Peters, 1983, Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin, Journal of Antimicrobial Chemotherapy, 11, 94, 10.1093/jac/11.1.94
Piercy, 1989, Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections, Antimicrobial Agents and Chemotherapy, 33, 128, 10.1128/AAC.33.1.128
Rahman, 1987, Mupirocin-resistant Staphylococcus aureus, Lancet, 2, 387, 10.1016/S0140-6736(87)92398-1
1986, Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus, 7, 193
Richardson, 1988, Another strain of methicillin-resistant Staphylococcus aureus epidemic in London, Lancet, 2, 748, 10.1016/S0140-6736(88)90224-3
Righter, 1987, Ciprofloxacin treatment of Staphylococcus aureus infections, Journal of Antimicrobial Chemotherapy, 20, 595, 10.1093/jac/20.4.595
Sande, 1975, Effect of rifampin on nasal carriage of Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, 7, 294, 10.1128/AAC.7.3.294
Selkon, 1980, The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci, Journal of Hospital Infection, 1, 41, 10.1016/0195-6701(80)90030-4
Shanson, 1985, Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unit, Journal of Hospital Infection, 6, 285, 10.1016/0195-6701(85)90032-5
Shanson, 1980, Operating theatre acquired infection with a gentamicin-resistant strain of Staphylococcus aureus: outbreaks in two hospitals attributable to one surgeon, Journal of Hospital Infection, 1, 171, 10.1016/0195-6701(80)90050-X
Smith, 1985, Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, 27, 688, 10.1128/AAC.27.5.688
Smith, 1989, Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations, Antimicrobial Agents and Chemotherapy, 33, 181, 10.1128/AAC.33.2.181
Sorrell, 1985, A prospective study of adverse reactions associated with vancomycin therapy, Journal of Antimicrobial Chemotherapy, 16, 235, 10.1093/jac/16.2.235
Sorrell, 1982, Vancomycin therapy for methicillin-resistant Staphylococcus aureus, Annals of Internal Medicine, 97, 344, 10.7326/0003-4819-97-3-344
Tuazon, 1978, In-vitro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, 13, 759, 10.1128/AAC.13.5.759
Varaldo, 1985, In-vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species, Antimicrobial Agents and Chemotherapy, 27, 615, 10.1128/AAC.27.4.615
Verbist, 1984, In-vitro activity and human pharmacokinetics of teicoplanin, Antimicrobial Agents and Chemotherapy, 26, 881, 10.1128/AAC.26.6.881
Watanakunakorn, 1981, Interaction between vancomycin and rifampin against Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, 19, 1089, 10.1128/AAC.19.6.1089
Wheat, 1981, Effect of rifampin on nasal carriers of coagulase-positive staphylococci, Journal of Infectious Diseases, 144, 177, 10.1093/infdis/144.2.177
Wilson, 1986, Teicoplanin-resistant coagulase-negative staphylococcus, Lancet, 2, 973, 10.1016/S0140-6736(86)90622-7
Woodley, 1961, The treatment of severe staphylococcal infections with vancomycin, Annals of Internal Medicine, 55, 235, 10.7326/0003-4819-55-2-235